These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16611704)

  • 1. Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.
    McDermott MM; Liu K; Guralnik JM; Ferrucci L; Green D; Greenland P; Tian L; Criqui MH; Lo C; Rifai N; Ridker PM; Zheng J; Pearce W
    J Gerontol A Biol Sci Med Sci; 2006 Apr; 61(4):374-9. PubMed ID: 16611704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
    McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
    Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.
    McDermott MM; Liu K; Greenland P; Guralnik JM; Criqui MH; Chan C; Pearce WH; Schneider JR; Ferrucci L; Celic L; Taylor LM; Vonesh E; Martin GJ; Clark E
    JAMA; 2004 Jul; 292(4):453-61. PubMed ID: 15280343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race.
    McDermott MM; Guralnik JM; Ferrucci L; Criqui MH; Greenland P; Tian L; Liu K; Tan J
    J Vasc Surg; 2005 Dec; 42(6):1131-7. PubMed ID: 16376203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
    McDermott MM; Ferrucci L; Liu K; Criqui MH; Greenland P; Green D; Guralnik JM; Ridker PM; Taylor LM; Rifai N; Tian L; Zheng J; Pearce WH; Schneider JR; Vonesh E
    J Am Geriatr Soc; 2005 Oct; 53(10):1688-96. PubMed ID: 16181167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical performance in peripheral arterial disease: a slower rate of decline in patients who walk more.
    McDermott MM; Liu K; Ferrucci L; Criqui MH; Greenland P; Guralnik JM; Tian L; Schneider JR; Pearce WH; Tan J; Martin GJ
    Ann Intern Med; 2006 Jan; 144(1):10-20. PubMed ID: 16389250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, weight change, and functional decline in peripheral arterial disease.
    McDermott MM; Criqui MH; Ferrucci L; Guralnik JM; Tian L; Liu K; Greenland P; Tan J; Schneider JR; Clark E; Pearce WH
    J Vasc Surg; 2006 Jun; 43(6):1198-204. PubMed ID: 16765239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease.
    McDermott MM; Ferrucci L; Guralnik JM; Tian L; Green D; Liu K; Tan J; Liao Y; Pearce WH; Schneider JR; Ridker P; Rifai N; Hoff F; Criqui MH
    J Am Coll Cardiol; 2007 Aug; 50(9):897-905. PubMed ID: 17719478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
    McDermott MM; Guralnik JM; Greenland P; Green D; Liu K; Ridker PM; Chan C; Criqui MH; Ferrucci L; Taylor LM; Pearce WH; Schneider JR; Oskin SI
    J Am Geriatr Soc; 2004 Nov; 52(11):1888-94. PubMed ID: 15507067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and functional decline in patients with and without peripheral arterial disease.
    Giri J; McDermott MM; Greenland P; Guralnik JM; Criqui MH; Liu K; Ferrucci L; Green D; Schneider JR; Tian L
    J Am Coll Cardiol; 2006 Mar; 47(5):998-1004. PubMed ID: 16516084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.
    McDermott MM; Greenland P; Guralnik JM; Ferrucci L; Green D; Liu K; Criqui MH; Schneider JR; Chan C; Ridker P; Pearce WH; Martin G; Clark E; Taylor L
    Vasc Med; 2004 May; 9(2):107-15. PubMed ID: 15521700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
    Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Pearce WH; Greenland P; Green D; Tan J; Garside DB; Guralnik J; Ridker PM; Rifai N; McDermott MM
    Ann Intern Med; 2008 Jan; 148(2):85-93. PubMed ID: 18195333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating blood markers and functional impairment in peripheral arterial disease.
    McDermott MM; Liu K; Ferrucci L; Tian L; Guralnik JM; Green D; Tan J; Liao Y; Pearce WH; Schneider JR; McCue K; Ridker P; Rifai N; Criqui MH
    J Am Geriatr Soc; 2008 Aug; 56(8):1504-10. PubMed ID: 18662216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity during daily life and functional decline in peripheral arterial disease.
    Garg PK; Liu K; Tian L; Guralnik JM; Ferrucci L; Criqui MH; Tan J; McDermott MM
    Circulation; 2009 Jan; 119(2):251-60. PubMed ID: 19118256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease.
    McDermott MM; Liu K; Ferrucci L; Tian L; Guralnik JM; Liao Y; Criqui MH
    J Am Coll Cardiol; 2011 Feb; 57(8):962-70. PubMed ID: 21329843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D status, functional decline, and mortality in peripheral artery disease.
    McDermott MM; Liu K; Ferrucci L; Tian L; Guralnik J; Kopp P; Van Horn L; Liao Y; Green D; Kibbe M; Sufit R; Zhao L; Criqui MH
    Vasc Med; 2014 Feb; 19(1):18-26. PubMed ID: 24442622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease.
    Herman SD; Liu K; Tian L; Guralnik JM; Ferrucci L; Criqui MH; Liao Y; McDermott MM
    J Am Geriatr Soc; 2009 Dec; 57(12):2246-52. PubMed ID: 19874404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels.
    Vidula H; Tian L; Liu K; Criqui MH; Ferrucci L; Guralnik JM; Green D; Ridker P; McDermott MM
    Am J Cardiol; 2010 May; 105(9):1348-52. PubMed ID: 20403491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.